How were (SGNT)'s earnings last quarter?

(SGNT) (NASDAQ:SGNT) announced its quarterly earnings results on Tuesday, August, 4th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.05 by $0.06. The business had revenue of $77.30 million for the quarter, compared to the consensus estimate of $83.28 million. The firm's revenue was up 11.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.09 EPS.

What other stocks do shareholders of (SGNT) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (SGNT) investors own include Mazor Robotics (MZOR) , Endocyte (ECYT) , Inovio Pharmaceuticals (INO) , Surgery Partners (SGRY) , Allena Pharmaceuticals (ALNA) , Catalyst Biosciences (CBIO) , Chatham Lodging Trust (CLDT) , CTI BioPharma (CTIC) , Daré Bioscience (DARE) and Dynavax Technologies (DVAX) .

NASDAQ:SGNT

(SGNT) (SGNT) Stock Price, News & Analysis

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)

Free SGNT Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $21.76
▼
$21.76
50-Day Range: N/A
52-Week Range: $10.55
▼
$21.88

Volume: N/A
Average Volume: 607,514 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (SGNT) alerts:

Ad Stansberry Research

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

About (SGNT) Stock (NASDAQ:SGNT)

Sagent Pharmaceuticals, Inc. is a specialty and generic pharmaceutical company. The Company is a provider of pharmaceuticals to the hospital market, which it sells primarily throughout North America. It is focused on developing, manufacturing, sourcing and marketing injectable pharmaceutical products to the hospital market. It operates through two segments: Sagent US, consisting of the Company's operations in the United States and the Sagent (China) Pharmaceuticals Co. Ltd. (SCP) manufacturing facility, and Omega, which is focused on the Canadian and international markets. It offers a range of products across anti-infective, oncology and critical care indications in a range of presentations, including single and multi-dose vials, pre-filled ready-to-use syringes and premix bags. Its Sagent US product portfolio includes approximately 60 marketed products that it offers in over 180 presentations, and its Omega segment offers over 50 products.

Ad Stansberry Research

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

SGNT Stock News Headlines

November 22, 2023 | msn.com

Fairfield man arrested in connection to Monday’s Vallejo shooting

August 22, 2023 | investing.com

Nihar Info Global Ltd (NIHR)

April 19, 2024 | Stansberry Research (Ad)

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

May 8, 2023 | thestreet.com

Changing Landscape for Generic-Drug Makers Creates Opportunities

April 30, 2023 | msn.com

Trying to find someone to take out all the caulking around my windows outside and redo, replace some cedar siding and all corners have holes from woodpeckers.

April 15, 2023 | msn.com

Olivia Wilde will helm a tv adaptation of A Visit from the Goon Squad

April 4, 2023 | msn.com

No One Cares About Kamala Harris

March 12, 2023 | msn.com

'Please be patient': MBTA update on speed restrictions

April 19, 2024 | Stansberry Research (Ad)

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

March 10, 2023 | msn.com

Chicago River Dyeing 2023, St. Patrick's Day Parade To Take Place This Weekend

February 22, 2023 | technews.tmcnet.com

LatticeFlow AG Appoints Global Technology Executive, Andre Boisvert, As Chairman of The Board

January 2, 2023 | thestreet.com

Sagent Pharmaceuticals (SGNT) Soared Today on Nichi-Iko Deal

December 3, 2022 | msn.com

WC Daily Preview: USA/NED, ARG/AUS open Round of 16

September 20, 2022 | investing.com

Salora International Ltd (SALI)

September 15, 2022 | msn.com

Character Designs That Drastically Changed

August 9, 2022 | msn.com

Jane Seymour hails close friend Olivia Newton-John for ‘changing the world’

August 8, 2022 | msn.com

What On Earth Will A Live-Action Pac-Man Movie Look Like?

July 14, 2022 | investing.com

Sungold Capital Ltd (SUNG)

December 2, 2021 | bbc.co.uk

Jeane Freeman: Inside The Pandemic

November 13, 2021 | dailymail.co.uk

Cleo Smith: Terrified neighbour of alleged doll-obsessed kidnapper fears locals will burn down house

November 11, 2021 | dailymail.co.uk

Cleo Smith: Forensics spray substance in Carnarvon, WA as Mark McGowan shoots down $1million reward

November 9, 2021 | dailymail.co.uk

Car of Cleo Smith's alleged abductor becomes focus of investigation as officers scour phone records

November 8, 2021 | msn.com

Hero detective who found missing girl Cleo Smith visits family home

November 8, 2021 | dailymail.co.uk

Hero detective who led Cleo Smith's rescue visits family home ahead of a week of crucial interviews

See More Headlines

Receive SGNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (SGNT) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/04/2015
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: Pharmaceuticals
Current Symbol: NASDAQ:SGNT
CUSIP: 78669210
CIK: 1369786
Web: www.sagentpharma.com
Phone: +1-847-9081604
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

SGNT Stock Analysis - Frequently Asked Questions

How were (SGNT)'s earnings last quarter?: (SGNT) (NASDAQ:SGNT) announced its quarterly earnings results on Tuesday, August, 4th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.05 by $0.06. The business had revenue of $77.30 million for the quarter, compared to the consensus estimate of $83.28 million. The firm's revenue was up 11.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.09 EPS.
What other stocks do shareholders of (SGNT) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (SGNT) investors own include Mazor Robotics (MZOR), Endocyte (ECYT), Inovio Pharmaceuticals (INO), Surgery Partners (SGRY), Allena Pharmaceuticals (ALNA), Catalyst Biosciences (CBIO), Chatham Lodging Trust (CLDT), CTI BioPharma (CTIC), Daré Bioscience (DARE) and Dynavax Technologies (DVAX).

This page (NASDAQ:SGNT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(SGNT) (SGNT) Stock Price, News & Analysis

About (SGNT) Stock (NASDAQ:SGNT)

SGNT Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

SGNT Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info